The human skin microbiome

Nature Reviews Microbiology

Volumn 16, Issue 3, 2018, Pages 143-155

  Byrd, Allyson L ^a,b,c,d   Belkaid, Yasmine ^c   Segre, Julia A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; AMPLICON; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CHRONIC WOUND; DNA SEQUENCE; HUMAN; IMMUNE DEFICIENCY; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SKIN FLORA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND INFECTION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL SKIN DISEASE; BACTERIUM; CLASSIFICATION; MICROBIOLOGY; MICROFLORA; SKIN;

BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; HUMANS; MICROBIOTA; SKIN; SKIN DISEASES, BACTERIAL;

EID: 85041798498     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.157     Document Type: Review

References (130)

1. Scharschmidt, T. C. & Fischbach, M. A. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome. Drug Discov. Today Dis. Mech. 10, e83-e89 (2013).
2. Belkaid, Y. & Segre, J. A. Dialogue between skin microbiota and immunity. Science 346, 954-959 (2014).
3. Grice, E. A. The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights. Genome Res. 25, 1514-1520 (2015).
4. Kong, H. H. et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22, 850-859 (2012).
5. Paulino, L. C., Tseng, C. H., Strober, B. E. & Blaser, M. J. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 44, 2933-2941 (2006).
6. Kong, H. H. & Segre, J. A. Skin microbiome: looking back to move forward. J. Invest. Dermatol. 132, 933-939 (2012).
7. Woese, C. R. & Fox, G. E. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc. Natl Acad. Sci. USA 74, 5088-5090 (1977).
8. Schoch, C. L. et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc. Natl Acad. Sci. USA 109, 6241-6246 (2012).
9. Meisel, J. S. et al. Skin microbiome surveys are strongly influenced by experimental design. J. Invest. Dermatol. 136, 947-956 (2016).
10. Zeeuwen, P. L. et al. Reply to Meisel et al. J. Investigative Dermatol. 137, 961-962 (2017).
11. Castelino, M. et al. Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform. BMC Microbiol. 17, 23 (2017).
12. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
13. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
14. Brooks, J. P. et al. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 15, 66 (2015).
15. Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z. & Forney, L. J. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE 7, e33865 (2012).
16. Gerasimidis, K. et al. The effect of DNA extraction methodology on gut microbiota research applications. BMC Res. Notes 9, 365 (2016).
17. Conlan, S. et al. Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol. 13, R64 (2012).
18. Tomida, S. et al. Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. mBio 4, e000030-13 (2013).
19. Bosi, E. et al. Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity. Proc. Natl Acad. Sci. USA 113, E3801-E3809 (2016).
20. Costello, E. K. et al. Bacterial community variation in human body habitats across space and time. Science 326, 1694-1697 (2009).
21. Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
22. Grice, E. A. & Segre, J. A. The skin microbiome. Nat. Rev. Microbiol. 9, 244-253 (2011).
23. Oh, J. et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59-64 (2014).
24. Findley, K. et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367-370 (2013).
25. Oh, J. et al. Temporal stability of the human skin microbiome. Cell 165, 854-866 (2016).
26. Hannigan, G. D. et al. The human skin double-stranded dna virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. mBio 6, e01578-15 (2015).
27. Feng, H., Shuda, M., Chang, Y. & Moore, P. S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319, 1096-1100 (2008).
28. Schloissnig, S. et al. Genomic variation landscape of the human gut microbiome. Nature 493, 45-50 (2013).
29. Faith, J. J. et al. The long-term stability of the human gut microbiota. Science 341, 1237439 (2013).
30. Tsai, Y. C. et al. Resolving the complexity of human skin metagenomes using single-molecule sequencing. mBio 7, e01948-15 (2016).
31. Holland, K. T., Greenman, J. & Cunliffe, W. J. Growth of cutaneous propionibacteria on synthetic medium; growth yields and exoenzyme production. J. Appl. Bacteriol. 47, 383-394 (1979).
32. Bruggemann, H. et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305, 671-673 (2004).
33. Marples, R. R., Downing, D. T. & Kligman, A. M. Control of free fatty acids in human surface lipids by Corynebacterium acnes. J. Invest. Dermatol. 56, 127-131 (1971).
34. Ingham, E., Holland, K. T., Gowland, G. & Cunliffe, W. J. Partial purification and characterization of lipase (EC 3.1.1.3) from Propionibacterium acnes. J. General Microbiol. 124, 393-401 (1981).
35. Gribbon, E. M., Cunliffe, W. J. & Holland, K. T. Interaction of Propionibacterium acnes with skin lipids in vitro. J. General Microbiol. 139, 1745-1751 (1993).
36. Mukherjee, S. et al. Sebum and hydration levels in specific regions of human face significantly predict the nature and diversity of facial skin microbiome. Sci. Rep. 6, 36062 (2016).
37. Webster, G. F., Ruggieri, M. R. & McGinley, K. J. Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin. Appl. Environ. Microbiol. 41, 1269-1270 (1981).
38. Wu, G. et al. Genus-wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet. 11, e1005614 (2015).
39. Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971-11975 (2010).
40. Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z. & Dominguez-Bello, M. G. The infant microbiome development: mom matters. Trends Mol. Med. 21, 109-117 (2015).
41. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
42. Faith, J. J., Colombel, J. F. & Gordon, J. I. Identifying strains that contribute to complex diseases through the study of microbial inheritance. Proc. Natl Acad. Sci. USA 112, 633-640 (2015).
43. Oh, J., Conlan, S., Polley, E. C., Segre, J. A. & Kong, H. H. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 4, 77 (2012).
44. Jo, J. H. et al. Diverse human skin fungal communities in children converge in adulthood. J. Invest. Dermatol. 136, 2356-2363 (2016).
45. Jo, J. H., Kennedy, E. A. & Kong, H. H. Topographical and physiological differences of the skin mycobiome in health and disease. Virulence 8, 324-333 (2016).
46. Havlickova, B., Czaika, V. A. & Friedrich, M. Epidemiological trends in skin mycoses worldwide. Mycoses 51 (Suppl. 4), 2-15 (2008).
47. Seebacher, C., Bouchara, J. P. & Mignon, B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 166, 335-352 (2008).
48. Kyriakis, K. P. et al. Pityriasis versicolor prevalence by age and gender. Mycoses 49, 517-518 (2006).
49. von Eiff, C., Becker, K., Machka, K., Stammer, H. & Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344, 11-16 (2001).
50. Weidenmaier, C., Goerke, C. & Wolz, C. Staphylococcus aureus determinants for nasal colonization. Trends Microbiol. 20, 243-250 (2012).
51. Bode, L. G. et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362, 9-17 (2010).
52. DeLeo, F. R., Otto, M., Kreiswirth, B. N. & Chambers, H. F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375, 1557-1568 (2010).
53. Proctor, R. A. Challenges for a universal Staphylococcus aureus vaccine. Clin. Infect. Dis. 54, 1179-1186 (2012).
54. Jansen, K. U., Girgenti, D. Q., Scully, I. L. & Anderson, A. S. Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects". Vaccine 31, 2723-2730 (2013).
55. Pamer, E. G. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352, 535-538 (2016).
56. Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455-459 (2015).
57. Iwase, T. et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465, 346-349 (2010).
58. Sugimoto, S. et al. Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195, 1645-1655 (2013).
59. Zipperer, A. et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535, 511-516 (2016).
60. Nakatsuji, T. et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl Med. 9, eaah4680 (2017).
61. Wollenberg, M. S. et al. Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. mBio 5, e01286-14 (2014).
62. Ramsey, M. M., Freire, M. O., Gabrilska, R. A., Rumbaugh, K. P. & Lemon, K. P. Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species. Front. Microbiol. 7, 1230 (2016).
63. Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S. & Lemon, K. P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio 7, e01725-15 (2016).
64. Christensen, G. J. et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genom. 17, 152 (2016).
65. Janek, D., Zipperer, A., Kulik, A., Krismer, B. & Peschel, A. High frequency and diversity of antimicrobial activities produced by nasal Staphylococcus strains against bacterial competitors. PLoS Pathog. 12, e1005812 (2016).
66. Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci. Transl Med. 8, 343ra81 (2016).
67. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
68. Buffie, C. G. & Pamer, E. G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790-801 (2013).
69. Iebba, V. et al. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 39, 1-12 (2016).
70. Leyden, J. J., McGinley, K. J., Mills, O. H. & Kligman, A. M. Propionibacterium levels in patients with and without acne vulgaris. J. Invest. Dermatol. 65, 382-384 (1975).
71. Fitz-Gibbon, S. et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J. Invest. Dermatol. 133, 2152-2160 (2013).
72. Kang, D., Shi, B., Erfe, M. C., Craft, N. & Li, H. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci. Transl Med. 7, 293ra103 (2015).
73. Picardo, M., Ottaviani, M., Camera, E. & Mastrofrancesco, A. Sebaceous gland lipids. Dermatoendocrinol. 1, 68-71 (2009).
74. Jahns, A. C. et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br. J. Dermatol. 167, 50-58 (2012).
75. Lomholt, H. B. & Kilian, M. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS ONE 5, e12277 (2010).
76. McDowell, A. et al. An expanded multilocus sequence typing scheme for Propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS ONE 7, e41480 (2012).
77. McDowell, A., Nagy, I., Magyari, M., Barnard, E. & Patrick, S. The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution. PLoS ONE 8, e70897 (2013).
78. Omer, H., McDowell, A. & Alexeyev, O. A. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies. Clin. Dermatol. 35, 118-129 (2017).
79. Balta, I. & Ozuguz, P. Vitamin B12-induced acneiform eruption. Cutane. Ocular Toxicol. 33, 94-95 (2014).
80. Sherertz, E. F. Acneiform eruption due to "megadose" vitamins B6 and B12. Cutis 48, 119-120 (1991).
81. Dupre, A., Albarel, N., Bonafe, J. L., Christol, B. & Lassere, J. Vitamin B-12 induced acnes. Cutis 24, 210-211 (1979).
82. Braun-Falco, O. & Lincke, H. The problem of vitamin B6/B12 acne. A contribution on acne medicamentosa [German]. MMW Munch. Med. Wochenschr. 118, 155-160 (1976).
83. Puissant, A., Vanbremeersch, F., Monfort, J. & Lamberton, J. N. A new iatrogenic dermatosis: acne caused by vitamin B 12 [French]. Bull. Soc. Fr. Dermatol. Syphiligr. 74, 813-815 (1967).
84. Johnson, T., Kang, D., Barnard, E. & Li, H. Strain-level differences in porphyrin production and regulation in Propionibacterium acnes elucidate disease associations. mSphere 1, e00023-15 (2016).
85. Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441-446 (2006).
86. The EArly Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium. Multi-ancestry genome-wide association study of 21, 000 cases and 95, 000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 47, 1449-1456 (2015).
87. Leyden, J. J., Marples, R. R. & Kligman, A. M. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-530 (1974).
88. Huang, J. T., Abrams, M., Tlougan, B., Rademaker, A. & Paller, A. S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123, e808-814 (2009).
89. Bath-Hextall, F. J., Birnie, A. J., Ravenscroft, J. C. & Williams, H. C. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br. J. Dermatol. 163, 12-26 (2010).
90. Byrd, A. L. et al. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci. Transl Med. 9, eaal4651 (2017).
91. Kennedy, E. A. et al. Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J. Allergy Clin. Immunol. 139, 166-172 (2017).
92. Chng, K. R. et al. Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat. Microbiol. 1, 16106 (2016).
93. Hanski, I. et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc. Natl Acad. Sci. USA 109, 8334-8339 (2012).
94. Fyhrquist, N. et al. Acinetobacter species in the skin microbiota protect against allergic sensitization and inflammation. J. Allergy Clin. Immunol. 134, 1301-1309.e11 (2014).
95. Zeeuwen, P. L. et al. Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin. J. Allergy Clin. Immunol. 139, 1368-1371 (2017).
96. Nakamura, Y. et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 503, 397-401 (2013).
97. Niebuhr, M. et al. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect. Immun. 79, 1615-1622 (2011).
98. Kaesler, S. et al. Staphylococcus aureus-derived lipoteichoic acid induces temporary T-cell paralysis independent of Toll-like receptor 2. J. Allergy Clin. Immunol. 138, 780-790.e6 (2016).
99. Zhang, L. J. et al. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science 347, 67-71 (2015).
100. Nakatsuji, T. et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J. Invest. Dermatol. 136, 2192-2200 (2016).
101. Kobayashi, T. et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 42, 756-766 (2015).
102. Oh, J. et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 23, 2103-2114 (2013).
103. Smeekens, S. P. et al. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J. Innate Immun. 6, 253-262 (2014).
104. Chu, E. Y. et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch. Dermatol. 148, 79-84 (2012).
105. Prompers, L. et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50, 18-25 (2007).
106. Valensi, P., Girod, I., Baron, F., Moreau-Defarges, T. & Guillon, P. Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes Metab. 31, 263-271 (2005).
107. Ramsey, S. D. et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22, 382-387 (1999).
108. Gardner, S. E., Hillis, S. L., Heilmann, K., Segre, J. A. & Grice, E. A. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 62, 923-930 (2013).
109. Loesche, M. et al. Temporal stability in chronic wound microbiota is associated with poor healing. J. Invest. Dermatol. 137, 237-244 (2017).
110. Martinez, C. et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am. J. Gastroenterol. 103, 643-648 (2008).
111. Kalan, L. et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. mBio 7, e01058-16 (2016).
112. Korem, T. et al. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples. Science 349, 1101-1106 (2015).
113. Segre, J. A. Epidermal barrier formation and recovery in skin disorders. J. Clin. Invest. 116, 1150-1158 (2006).
114. Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12, 503-516 (2012).
115. Kong, H. H. et al. Performing skin microbiome research: a method to the madness. J. Invest. Dermatol. 137, 561-568 (2017).
116. Alexeyev, O. A. Bacterial landscape of human skin: seeing the forest for the trees. Exp. Dermatol. 22, 443-446 (2013).
117. Alexeyev, O. A. & Jahns, A. C. Sampling and detection of skin Propionibacterium acnes: current status. Anaerobe 18, 479-483 (2012).
118. Grice, E. A. et al. A diversity profile of the human skin microbiota. Genome Res. 18, 1043-1050 (2008).
119. Nakatsuji, T. et al. The microbiome extends to subepidermal compartments of normal skin. Nat. Commun. 4, 1431 (2013).
120. Zeeuwen, P. L. et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 13, R101 (2012).
121. Nagy, I. et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 8, 2195-2205 (2006).
122. Naik, S. et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520, 104-108 (2015).
123. Naik, S. et al. Compartmentalized control of skin immunity by resident commensals. Science 337, 1115-1119 (2012).
124. PrabhuDas, M. et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat. Immunol. 12, 189-194 (2011).
125. Scharschmidt, T. C. et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43, 1011-1021 (2015).
126. Belkaid, Y. & Tamoutounour, S. The influence of skin microorganisms on cutaneous immunity. Nat. Rev. Immunol. 16, 353-366 (2016).
127. Belkaid, Y. & Harrison, O. J. Homeostatic immunity and the microbiota. Immunity 46, 562-576 (2017).
128. Hand, T. W. et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 337, 1553-1556 (2012).
129. Otto, M. Staphylococcus epidermidis - the 'accidental' pathogen. Nat. Rev. Microbiol. 7, 555-567 (2009).
130. Newell, E. W. & Davis, M. M. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat. Biotechnol. 32, 149-157 (2014).